- Home
- GSIW vs SXTP Comparison
GSIW vs SXTP Comparison
Compare GSIW & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- SXTP
- Stock Information
- Founded
- GSIW 2016
- SXTP 2010
- Country
- GSIW Hong Kong
- SXTP United States
- Employees
- GSIW N/A
- SXTP N/A
- Industry
- GSIW
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- GSIW
- SXTP Health Care
- Exchange
- GSIW Nasdaq
- SXTP Nasdaq
- Market Cap
- GSIW 8.1M
- SXTP 6.7M
- IPO Year
- GSIW 2023
- SXTP 2023
- Fundamental
- Price
- GSIW $0.15
- SXTP $1.48
- Analyst Decision
- GSIW
- SXTP Buy
- Analyst Count
- GSIW 0
- SXTP 2
- Target Price
- GSIW N/A
- SXTP $3.00
- AVG Volume (30 Days)
- GSIW 5.9M
- SXTP 296.8K
- Earning Date
- GSIW 01-01-0001
- SXTP 11-13-2025
- Dividend Yield
- GSIW N/A
- SXTP N/A
- EPS Growth
- GSIW N/A
- SXTP N/A
- EPS
- GSIW N/A
- SXTP N/A
- Revenue
- GSIW $5,368,221.00
- SXTP $984,494.00
- Revenue This Year
- GSIW N/A
- SXTP $81.41
- Revenue Next Year
- GSIW N/A
- SXTP $83.17
- P/E Ratio
- GSIW N/A
- SXTP N/A
- Revenue Growth
- GSIW 283.23
- SXTP 128.70
- 52 Week Low
- GSIW $0.09
- SXTP $1.22
- 52 Week High
- GSIW $1.79
- SXTP $12.45
- Technical
- Relative Strength Index (RSI)
- GSIW 47.93
- SXTP 49.35
- Support Level
- GSIW $0.15
- SXTP $1.43
- Resistance Level
- GSIW $0.16
- SXTP $1.52
- Average True Range (ATR)
- GSIW 0.02
- SXTP 0.13
- MACD
- GSIW 0.00
- SXTP -0.01
- Stochastic Oscillator
- GSIW 17.99
- SXTP 14.29
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.